Kiora Pharmaceuticals Inc expected to post a loss of 7 cents a share - Earnings Preview

Kiora Pharmaceuticals

03/05/2024 15:56

* Kiora Pharmaceuticals Inc  KPRX.OQ   KPRX.O  is expected
to show
no change in quarterly revenue when it reports  results on May 7
(estimated) for the period ending March 31 2024
    * 
    * ​LSEG's mean analyst estimate for Kiora Pharmaceuticals
Inc is
for a loss of 7 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 33.5%
in the last three months. ​
    * Wall Street's median 12-month price target for Kiora
Pharmaceuticals Inc is $3.00​, above​ its last closing price
of $0.54. ​​​

This summary was machine generated May 3 at 14:56 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)